Medinteract’s co-founder, Dr. John Dougherty and Dr. Alan Solomon from the University of Tennessee Medical Center, discuss the exciting research collaboration with Eli Lilly and Co. and the newly FDA-approved Amyvid which is used in the early diagnosis of mild cognitive impairment (MCI) and early Alzheimer’s disease.
Archive for April, 2012
Dr. Monica Crane, one of our advising physicians, recently spoke with WATE News about Pat Summitt’s impact on the Alzheimer’s community. http://www.wate.com/story/17538659/geriatric-specialist-discusses-pat-summitts-impact-on-the-alzheimers-community
Congratulations to Pat Summitt for being awarded the Presidential Medal of Freedom! She has been a role model to millions of people throughout her career and has recently become a key figure in the fight against Alzheimer’s. Her courage in publicly announcing her diagnosis has brought needed awareness to the disease and stressed the importance of early detection. As a member of the Knoxville community, we are excited to support Pat Summitt and her foundation in the fight against Alzheimer’s disease.